COVID-19 Impact

You may see some delays in posting new content due to COVID-19. If you have any questions, please submit a message to PSNet Support.
 

PSNet: Patient Safety Network
Journal Article
Study

Medication safety in the ambulatory chemotherapy setting.

Gandhi TK, Bartel SB, Shulman LN, et al. Cancer. 2005;104.

Chemotherapeutic drugs share the characteristic of providing life-saving benefits at the expense of substantial toxicity if not administered and monitored carefully. With ongoing advances in such therapy and a growing shift to outpatient treatment in infusion clinics, this prospective cohort study evaluated more than 10,000 medication orders at a cancer institute in both adult and pediatric settings. Investigators discovered an overall error rate of 3%, with the majority of errors deemed to have a potential for harm. Most of the errors never reached the patient as nurses and pharmacists caught them before administration. Of note, the reported error rate of 3% was lower than past studies in inpatient (5%) and outpatient settings (8%). The authors conclude by sharing the prevention strategies that came from their local findings and how the complexity of outpatient oncology treatment warrants ongoing attention.